首页 › 基金 › Spruce Street Capital LP › CRVS

Spruce Street Capital LP 对 CRVS 的持仓历史

CORVUS PHARMACEUTICALS INC · 医疗保健

Spruce Street Capital LP 在 Q3 2026 的 13F 申报中披露持有 CRVS(CORVUS PHARMACEUTICALS INC)231,585 股,市值约 US$2.7M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 37 位。 Spruce Street Capital LP 最近 3 个申报季度中有 3 个季度披露了 CRVS 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)231.59K 股
申报持仓市值$2.67M
组合权重0.42%
首次申报Q1 2026
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Spruce Street Capital LP 对 CRVS 的持仓演变

Spruce Street Capital LP 于 Q1 2026 首次披露 CRVS 持仓:231,585 股(约 US$3.4M)。 该持仓在 Q2 2026 达到峰值 231,585 股,市值约 US$3.5M。 在 3 次申报中,Spruce Street Capital LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 231,585 股、市值约 US$2.7M。

逐季持仓明细

季度股数金额变化
Q1 2026 231.59K $3.39M 新进
Q2 2026 231.59K $3.46M 持有
Q3 2026 231.59K $2.67M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CRVS 与 13F 数据

CRVS(CORVUS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 65 只申报持有 CRVS,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), PERCEPTIVE ADVISORS LLC (US$39.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CRVS 的基金

查看 CRVS 的全部基金持有人 →

常见问题

How long has Spruce Street Capital LP held CRVS?

Spruce Street Capital LP has disclosed CRVS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Spruce Street Capital LP's current position in CRVS?

As of Q3 2026, Spruce Street Capital LP holds 231.59K shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $2.67M, representing 0.42% of its reported portfolio and ranking #37.

Has Spruce Street Capital LP been buying or selling CRVS?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in CRVS. The position peaked in Q2 2026 at 231.59K shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, PERCEPTIVE ADVISORS LLC, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.